BRCA1 and cancer: These data suggest that unlike BRCAmut cancers, where BRCA loss is a genetically ‘fixed’ deficiency state, BRCA1meth cancers are highly adaptive to genotoxin exposure and, through reversal of promoter methylation, recover BRCA1 expression and become resistant to therapy.